Clustering data with hclust algorithm for Effects of the Kinase Inhibitor Sorafenib on Liver Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). (Study ST000577)

GC POSITIVE ION MODE (Analysis AN000887)
MetaboliteStructureF1F2
AsparagineME1697620.951.05
HydroxyprolinesME1697940.981.03
alpha-MonostearinME1697560.971.03
Aminomalonic acidME1697580.971.03
SqualeneME1698220.971.02
TyrosineME1698340.981.02
Tetradecanedioic acidME1698280.981.02
Succinic acidME1698250.981.02
Myoinositol-2-phosphateME1698030.981.02
Erythritol/TheitolME1697820.981.02
C16 HydrocarbonME1697700.981.02
Dehydroascorbic acid (possibly alpha-ketoglutarate)ME1697770.981.02
UreaME1698371.001.00
UracilME1698361.001.00
Tiglic acidME1698311.001.00
ThreonineME1698301.001.00
Threonic acid/erythronic acidME1698291.001.00
TaurineME1698271.001.00
SiloxanesME1698201.001.00
PseudouridineME1698171.001.00
PhenylalanineME1698141.001.00
PhenolME1698131.001.00
PentitolsME1698121.001.00
Pentadecanoic acid/HexadecanolME1698111.001.00
O-MethylphosphateME1698081.001.00
N-Methylalanine/2-Aminobutanoic acid/N-EthylglycineME1698051.001.00
MyoinositolME1698021.001.00
MethionineME1698001.001.00
Malonic acidME1697991.001.00
Lauric acidME1697981.001.00
Isoleucine/LeucineME1697961.001.00
Hexanoic acid (and/or Glycolic acid)ME1697931.001.00
Glyoxylic acidME1697911.001.00
Glycerol 1-phosphateME1697901.001.00
gamma-TocopherolME1697871.001.00
gamma-Hydroxybutyric acidME1697861.001.00
Fumaric acidME1697851.001.00
Fructose or similar ketohexoseME1697841.001.00
EthanolamineME1697831.001.00
Docosahexaenoic acidME1697801.001.00
Dehydroalanine (possibly from cysteine)ME1697761.001.00
C25 hydrocarbonME1697721.001.00
C11 hydrocarbonME1697681.001.00
C10 hydrocarbonME1697671.001.00
beta-SitosterolME1697661.001.00
Aspartic acidME1697631.001.00
Ascorbic acid/Isoascorbic acidME1697611.001.00
Arachidonic acid (also Eicosapentaenoic acid)ME1697601.001.00
AldopentosesME1697531.001.00
2-HydroxypyridineME1697491.001.00
3-Phosphoglyceric acidME1697501.001.00
Tryptamine/NorepinephrineME1698330.991.01
Sucrose and similar disaccharidesME1698260.991.01
Stearic acidME1698240.991.01
StearamideME1698230.991.01
SpermidineME1698210.991.01
SerineME1698190.991.01
Phosphoenolpyruvic acidME1698150.991.01
O-PhosphocolamineME1698090.991.01
Nonanoic acidME1698070.991.01
Nonadecanoic acidME1698060.991.01
Myristic acid or PentadecanolME1698040.991.01
Inosine/AdenosineME1697950.991.01
Heptadecanoic acid/OctadecanolME1697920.991.01
Gly-ProME1697890.991.01
Glutathione (reduced)ME1697880.991.01
Dihydroxyacetone phosphateME1697790.991.01
deuterated Myristic Acid (RTL std)ME1697780.991.01
CreatinineME1697740.991.01
CampesterolME1697730.991.01
C17 hydrocarbonME1697710.991.01
Benzoic acidME1697640.991.01
alpha-TocopherolME1697570.991.01
alpha-MonopalmitinME1697550.991.01
Acetoacetate/2-Aminoisobutanoic acidME1697510.991.01
Adenosine/InosineME1697520.991.01
2-Aminoadipic acidME1697481.030.98
Pyruvic acidME1698181.020.98
Unknown-possibly propylene glycolME1698351.020.98
Methionine sulfoxideME1698011.020.99
TrisaccharideME1698321.010.99
ProlineME1698161.010.99
Pantothenic acidME1698101.010.99
Lactic acidME1697971.010.99
Docosanoic acidME1697811.010.99
Decanoic acidME1697751.010.99
C12 hydrocarbonME1697691.010.99
beta-Hydroxybutyric acidME1697651.010.99
alpha Ketoglutaric acidME1697541.010.99
Arachidic acid/ 1-HeneicosanolME1697591.010.99

Factors:

F1Vehicle (PBS) Control Treatment:30 mg/kg Sorafenib Treatment
F2Vehicle (PBS) Control Treatment:Vehicle (PBS) Control Treatment
Data matrix
  logo